Hydroxycarbamide oral solution (Xromi®) is accepted for restricted use within NHSScotland

Approved for the prevention of vaso-occlusive complications of sickle cell disease in patients >2 years, restricted to children who are too young to be able to swallow capsules / tablets and adults and adolescents who have difficulty in swallowing solid oral dosage forms.


Scottish Medicines Consortium